8-K filing — Q32 Bio Inc. (QTTB)
Filed: 2026-09-14 AccNo: 0001193125-26-389836 Size: 167 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
HC Wainwright & Co. Maintains Buy on Q32 Bio, Raises Price Target to $36
HC Wainwright & Co. analyst Joseph Pantginis maintains Q32 Bio (NASDAQ:QTTB) with a Buy and raises the price target from $13 to $36.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Morgan Stanley Initiates Coverage On Q32 Bio with Overweight Rating, Announces Price Target of $34
Q32 Bio Q2 EPS $(0.44) Beats $(0.54) Estimate
Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.54) by 18.52 percent. This is a 43.59 percent increase over losses of $(0.78) per share from the same
Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on top names. For a complete view, see analyst ratings page. See how others view these stocks.